Back to Newsroom
Back to Newsroom

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NTNX, HSACW and XL

Thursday, 11 March 2021 06:30 AM

The Klein Law Firm

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / March 11, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Nutanix, Inc. (NASDAQ:NTNX)
Class Period: March 1, 2018 - May 30, 2019
Lead Plaintiff Deadline: March 22, 2021

The complaint alleges that during the class period Nutanix, Inc. made materially false and/or misleading statements and/or failed to disclose that: Nutanix had materially overstated its customer base and sales productivity, and that such overstatements would eventually cause the Company's stock price to drop dramatically.

Learn about your recoverable losses in NTNX: http://www.kleinstocklaw.com/pslra-1/nutanix-inc-loss-submission-form?id=13560&from=1

Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (NASDAQ:HSACW)
Class Period: October 2, 2019 - February 1, 2021
Lead Plaintiff Deadline: April 20, 2021

According to the complaint, Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) HSAC had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401; (ii) IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA; (iii) the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in HSACW: http://www.kleinstocklaw.com/pslra-1/immunovant-inc-f-k-a-health-sciences-acquisitions-corporation-loss-submission-form?id=13560&from=1

XL Fleet Corp. (NYSE:XL)
Class Period: October 2, 2020 - March 2, 2021
Lead Plaintiff Deadline: May 7, 2021

The XL lawsuit alleges that XL Fleet Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) XL Fleet's salespeople were pressured to inflate their sales pipelines to boost the Company's reported sales and backlog; (2) at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) XL's technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in XL: http://www.kleinstocklaw.com/pslra-1/xl-fleet-corp-loss-submission-form?id=13560&from=1

The Klein Law Firm, Thursday, March 11, 2021, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: